Risk factors associated with augmented renal clearance in a mixed intensive care unit population : a retrospective study
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG..
BACKGROUND: Augmented renal clearance is increasingly recognized in critically ill patients. This condition may lead to suboptimal dosing of renally excreted medications.
AIM: Our primary objective was to identify demographic and clinical factors associated with augmented renal clearance in a mixed critically ill population.
METHOD: This retrospective single center observational cohort study evaluated patients admitted in a mixed adult intensive care unit for augmented renal clearance, defined as a creatinine clearance of ≥ 130 ml/min/1.73m2, through weekly 24-h urine collection. Variables associated with augmented renal clearance were identified using univariate analysis, then served as covariates in a backward stepwise logistic regression. Goodness-of-fit of the model was assessed and receiver operating characteristic curve was generated.
RESULTS: Augmented renal clearance was observed in 25.3% of the study cohort (n = 324). Age below 50 years (adjusted odds ratio 7.32; 95% CI 4.03-13.29, p < 0.001), lower serum creatinine at intensive care admission (adjusted odds ratio 0.97; 95% CI 0.96-0.99, p < 0.001) and trauma admission (adjusted odds ratio 2.26; 95% CI 1.12-4.54, p = 0.022) were identified as independent risk factors. Our model showed acceptable discrimination in predicting augmented renal clearance (Area under receiver operating characteristic curve (0.810; 95% CI 0.756-0.864, p < 0.001)).
CONCLUSION: We identified age below 50 years, lower serum creatinine upon intensive care admission and trauma as independent risk factors for augmented renal clearance, consistent with the literature suggesting that patients with low serum creatinine upon admission could have a higher risk of developing augmented renal clearance.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2022 |
|---|---|
| Erschienen: |
2022 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:44 |
|---|---|
| Enthalten in: |
International journal of clinical pharmacy - 44(2022), 6 vom: 14. Dez., Seite 1277-1286 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Bing, Emily [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
AYI8EX34EU |
|---|
| Anmerkungen: |
Date Completed 06.12.2022 Date Revised 06.12.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1007/s11096-022-01458-9 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM34354413X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM34354413X | ||
| 003 | DE-627 | ||
| 005 | 20231226020710.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2022 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1007/s11096-022-01458-9 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1145.xml |
| 035 | |a (DE-627)NLM34354413X | ||
| 035 | |a (NLM)35834093 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Bing, Emily |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Risk factors associated with augmented renal clearance in a mixed intensive care unit population |b a retrospective study |
| 264 | 1 | |c 2022 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.12.2022 | ||
| 500 | |a Date Revised 06.12.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG. | ||
| 520 | |a BACKGROUND: Augmented renal clearance is increasingly recognized in critically ill patients. This condition may lead to suboptimal dosing of renally excreted medications | ||
| 520 | |a AIM: Our primary objective was to identify demographic and clinical factors associated with augmented renal clearance in a mixed critically ill population | ||
| 520 | |a METHOD: This retrospective single center observational cohort study evaluated patients admitted in a mixed adult intensive care unit for augmented renal clearance, defined as a creatinine clearance of ≥ 130 ml/min/1.73m2, through weekly 24-h urine collection. Variables associated with augmented renal clearance were identified using univariate analysis, then served as covariates in a backward stepwise logistic regression. Goodness-of-fit of the model was assessed and receiver operating characteristic curve was generated | ||
| 520 | |a RESULTS: Augmented renal clearance was observed in 25.3% of the study cohort (n = 324). Age below 50 years (adjusted odds ratio 7.32; 95% CI 4.03-13.29, p < 0.001), lower serum creatinine at intensive care admission (adjusted odds ratio 0.97; 95% CI 0.96-0.99, p < 0.001) and trauma admission (adjusted odds ratio 2.26; 95% CI 1.12-4.54, p = 0.022) were identified as independent risk factors. Our model showed acceptable discrimination in predicting augmented renal clearance (Area under receiver operating characteristic curve (0.810; 95% CI 0.756-0.864, p < 0.001)) | ||
| 520 | |a CONCLUSION: We identified age below 50 years, lower serum creatinine upon intensive care admission and trauma as independent risk factors for augmented renal clearance, consistent with the literature suggesting that patients with low serum creatinine upon admission could have a higher risk of developing augmented renal clearance | ||
| 650 | 4 | |a Observational Study | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Augmented renal clearance | |
| 650 | 4 | |a Critically ill | |
| 650 | 4 | |a Intensive care unit | |
| 650 | 4 | |a Retrospective cohort | |
| 650 | 4 | |a Serum creatinine | |
| 650 | 7 | |a Creatinine |2 NLM | |
| 650 | 7 | |a AYI8EX34EU |2 NLM | |
| 700 | 1 | |a Archambault, Kym |e verfasserin |4 aut | |
| 700 | 1 | |a Sananikone, Alice |e verfasserin |4 aut | |
| 700 | 1 | |a Nguyen, Kim-Dan |e verfasserin |4 aut | |
| 700 | 1 | |a Fang, Yi Tong |e verfasserin |4 aut | |
| 700 | 1 | |a Jabamikos, Caren |e verfasserin |4 aut | |
| 700 | 1 | |a Gras, Cécile |e verfasserin |4 aut | |
| 700 | 1 | |a Marsot, Amélie |e verfasserin |4 aut | |
| 700 | 1 | |a Duceppe, Marc-Alexandre |e verfasserin |4 aut | |
| 700 | 1 | |a Perreault, Marc M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of clinical pharmacy |d 2011 |g 44(2022), 6 vom: 14. Dez., Seite 1277-1286 |w (DE-627)NLM203361717 |x 2210-7711 |7 nnns |
| 773 | 1 | 8 | |g volume:44 |g year:2022 |g number:6 |g day:14 |g month:12 |g pages:1277-1286 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1007/s11096-022-01458-9 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 44 |j 2022 |e 6 |b 14 |c 12 |h 1277-1286 | ||